AU7996800A - Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer - Google Patents

Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer

Info

Publication number
AU7996800A
AU7996800A AU79968/00A AU7996800A AU7996800A AU 7996800 A AU7996800 A AU 7996800A AU 79968/00 A AU79968/00 A AU 79968/00A AU 7996800 A AU7996800 A AU 7996800A AU 7996800 A AU7996800 A AU 7996800A
Authority
AU
Australia
Prior art keywords
diagnostic
prostate cancer
differentially expressed
therapeutic uses
gene differentially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79968/00A
Inventor
Pablo Garcia
Jimmy Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU7996800A publication Critical patent/AU7996800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU79968/00A 1999-10-07 2000-10-06 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer Abandoned AU7996800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15856999P 1999-10-07 1999-10-07
US60158569 1999-10-07
US68098500A 2000-10-05 2000-10-05
US09680985 2000-10-05
PCT/US2000/027638 WO2001025489A2 (en) 1999-10-07 2000-10-06 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer

Publications (1)

Publication Number Publication Date
AU7996800A true AU7996800A (en) 2001-05-10

Family

ID=26855153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79968/00A Abandoned AU7996800A (en) 1999-10-07 2000-10-06 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer

Country Status (2)

Country Link
AU (1) AU7996800A (en)
WO (1) WO2001025489A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288346B2 (en) * 2000-08-22 2005-11-03 Albert Einstein Healthcare Network Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047793B1 (en) * 1998-01-21 2006-11-15 Dianon Systems, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Also Published As

Publication number Publication date
WO2001025489A3 (en) 2002-02-14
WO2001025489A2 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
AU3619400A (en) Human prostate cancer associated gene sequences and polypeptides
AU3316600A (en) Gene expression in bladder tumors
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU1922301A (en) Differential gene expression in cancer
AU2001253119A1 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
AU5691699A (en) Human genes differentially expressed in colorectal cancer
AU2637100A (en) Delivery system and methods for gene therapy
AU1453301A (en) Methods of reversing drug resistance in cancer cells
AU4253799A (en) Cancer therapy with cationic peptides
AU2238499A (en) Androgen-metabolic gene mutations and prostate cancer risk
AU8026300A (en) Sodd gene expression in cancer
AU2674599A (en) A novel npg-1 gene that is differentially expressed in prostate tumors
AU2506499A (en) Cea/nca-based differentiation cancer therapy
AU5416700A (en) Differentially expressed genes in prostate cancer
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU4135600A (en) Prostate cancer associated human fibronectin gene and biallelic markers
AU7996800A (en) Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU1576501A (en) Methods to enhance and confine gene expression in cancer therapy
AU3349997A (en) Reg gene expression in cancer tissue
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU4462600A (en) Novel prostate-restricted gene expressed in prostate cancer
AU2001236782A1 (en) 34p3d7: a tissue specific protein highly expressed in prostate cancer
AU5632500A (en) Cancer associated antigens and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase